Abstract
Several legal issues have emerged from the debate over laetrile, an unproven cancer treatment banned from interstate commerce by federal drug laws. The writer reviews these issues and suggests that recent state laws legalizing the manufacture and sale of laetrile within those states are subject to preemption for interfering with the enforcement of the federal ban on drugs of unproven efficacy.
How to Cite
20 Ariz. L. Rev. 825 (1978)
96
Views
159
Downloads